Omada Health was founded in 2011 by Adrian James, Andrew Di Michele, and Sean Duffy. CEO Duffy told Bloomberg in 2022 that while he intends to eventually take the company public, he "plans to stay independent for now...Especially given the current state of the public markets." Duffy added that "I tell the company that our job here is to make sure that when we make that flip to public it doesn’t feel like we’re doing anything differently." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Omada Health is a digital health firm that uses virtual consultations and monitoring devices to provide remote care for patients who suffer from chronic illness. In 2020 the company acquired Physera, a telehealth provider that specializes in musculoskeletal care. Omada Health has raised more than $440 million in venture capital funding from investors including Fidelity Management & Research Company, aMoon, Perceptive Advisors, Wellington Management, and Civilization Ventures. A $192 million Series E funding round brought the company's post-money valuation to more than $1 billion.

Register for Details

For more details on financing and valuation for Omada Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Omada Health

To invest in Omada Health pre-IPO

Can you invest in Omada Health pre-IPO?

Omada Health is a privately held company and is not publicly traded, therefore investing in Omada Health pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Omada Health before it goes public?

You can seek to sell your shares in Omada Health while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Omada Health shares?

To determine the value of your Omada Health shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Omada Health shares. You can also learn more about how to sell your private shares before getting started.

Is Omada Health a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Omada Health potential IPO

Will Omada Health go IPO?

Omada Health has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Omada Health’s IPO price?

The Omada Health IPO price does not exist at this time, as Omada Health is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Omada Health register for Forge Markets, today.

When was Omada Health founded?

Omada Health was founded in 2011.

What is Omada Health funding to date?

Omada Health has raised $919.75MM to date.

Who are Omada Health’s major investors?

Civilization Ventures
Founder Collective
Us Venture Partners
Humana
Cigna
Sanofi Genzyme Bioventures
Designer Fund
Undisclosed Investors
Fidelity
Humana Ventures
Perceptive Advisors
The Vertical Group
Triplepoint Capital
Wellington Management
Kapor Capital
Norwest Venture Partners
Cigna Ventures
Kaiser Permanente Ventures
Providence Ventures
Healthtech Capital
Ideo Futures
Andreessen Horowitz
Rock Health
New Enterprise Associates
Sanofi-Genzyme Bioventures
U.S. Venture Partners
Amoon
Ge Ventures
Drx Capital

Omada Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
02/23/2022 Series E $192MM $xx.xx $102.28B Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management
Price per Share
$xx.xx
Shares Outstanding
32,025,620
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amoon, Civilization Ventures, Fidelity, Perceptive Advisors, Wellington Management
03/16/2021 Series D-1 $27MM $xx.xx $78.08B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
4,503,601
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
05/19/2020 Series D $112.47MM $xx.xx $61.29B Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management
Price per Share
$xx.xx
Shares Outstanding
22,330,212
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Cigna Ventures, Civilization Ventures, Kaiser Permanente Ventures, Norwest Venture Partners, Perceptive Advisors, Providence Ventures, Sanofi-Genzyme Bioventures, Us Venture Partners, Wellington Management
05/10/2017 Series C-1 $49.99MM $xx.xx $32.02B Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners
Price per Share
$xx.xx
Shares Outstanding
13,357,797
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Cigna, Civilization Ventures, Drx Capital, Ge Ventures, Humana, Kaiser Permanente Ventures, Norwest Venture Partners, Providence Ventures, Sanofi Genzyme Bioventures, U.S. Venture Partners
10/01/2015 Series C $48.67MM $xx.xx $21.64B Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners
Price per Share
$xx.xx
Shares Outstanding
15,385,707
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Designer Fund, Drx Capital, Ge Ventures, Humana Ventures, Ideo Futures, Norwest Venture Partners, Providence Ventures, Rock Health, Us Venture Partners
04/09/2014 Series B $23.33MM $xx.xx $6.06B Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners
Price per Share
$xx.xx
Shares Outstanding
19,724,378
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Kaiser Permanente Ventures, The Vertical Group, U.S. Venture Partners
03/21/2013 Series A $6.43MM $xx.xx $1.61B Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners
Price per Share
$xx.xx
Shares Outstanding
12,027,426
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founder Collective, Healthtech Capital, Kapor Capital, New Enterprise Associates, The Vertical Group, Triplepoint Capital, U.S. Venture Partners
Updated on: Nov 24, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.